Sporadic late onset paroxysmal cerebellar ataxia in four unrelated patients: a new disease?
We describe a peculiar form of late onset paroxysmal cerebellar ataxia including clinical features similar to episodic ataxia type 2 (EA2) but unresponsive to acetazolamide. Four unrelated patients were clinically investigated. Neuropathological examination was performed in one patient and molecular analysis in all four. All 47 exons of CACNA1A were screened by a combination of single-strand conformer polymorphism and sequencing analysis in three patients. In addition, the length of the CAG repeat was determined in all four patients. The four patients were in their 60s at the onset of the disease, which was characterized by cerebellar ataxia attacks lasting from a few minutes to 1-2 h and occurring mainly in the morning. In the interictal period a nystagmus was present together with a slowly progressive cerebellar ataxia over the years. The neuropathological examination disclosed a dramatic loss of Purkinje cells mainly in the vermis. Moreover, certain cerebellar granular neurons had a strong cytoplasmic staining at immunopathological examination with an anti-tau protein serum. Search for truncating mutations or CAG repeat expansion in CACNA1A was negative. This late-onset paroxysmal cerebellar ataxia with neuropathological lesions restricted to Purkinje cells and with negative results both for truncating mutations and CAG expansion in the CACNA1A gene represents a new entity. Further studies are needed to delineate the underlying process.
Julien
J
J
Departments of Neurology and Neuropathology, CHU Bordeaux, 33604 Pessac, France.
Denier
C
C
Ferrer
X
X
Ducros
A
A
Saintarailles
J
J
Lagueny
A
A
Tournier-Lasserve
E
E
Vital
C
C
D000086:Acetazolamide / Q000627:therapeutic use; D000368:Aged; D000927:Anticonvulsants / Q000627:therapeutic use; D015220:Calcium Channels / Q000235:genetics; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011689:Purkinje Cells / Q000473:pathology*; D013132:Spinocerebellar Degenerations / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology*; D020864:Calcium Channels, N-Type
D000086:Acetazolamide; D000927:Anticonvulsants; D015220:Calcium Channels; C105656:CACNA1A protein, human; D020864:Calcium Channels, N-Type